Antidepressant Treatment of Depression: A Metaanalysis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objective: To carry out a metaanalysis of antidepressant studies to calculate the effect sizes for antidepressant effect in depressive disorder. Method: A metaanalysis of all antidepressant studies that included an active comparison drug as well as placebo was used to calculate the effect size. Articles were selected from a MEDLINE search for the period January 1966 to June 1995. Forty-nine studies were included in the metaanalysis. Results: The effect sizes for antidepressant treatment are moderately larger than for placebo. A larger effect size was observed in studies where objective diagnostic criteria for depression were used. Conclusions: We conclude that the superior efficacy of antidepressants over placebo can be demonstrated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Thomson, J., Rankin, H., Ashcroft, G. W., Yates, C. M., McQueen, J. K., & Cummings, S. W. (1982) · Psychological Medicine · doi:10.1017/s0033291700049047 · Cited by 177
A Comparison of Venlafaxine, Trazodone, and Placebo in Major Depression
CUNNINGHAM, L. A., BORISON, R. L., CARMAN, J. S., CHOUINARD, G., CROWDER, J. E., DIAMOND, B. I., FISCHER, D. E., & HEARST, E. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199404000-00003 · Cited by 159
Cited by
Imputing missing standard deviations in meta-analyses can provide accurate results
Furukawa, T. A., Barbui, C., Cipriani, A., Brambilla, P., & Watanabe, N. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.06.006 · Cited by 1,568
The Journal of Mental Health Policy and Economics
(2006) · The Journal of Mental Health Policy and Economics · doi:10.1002/(issn)1099-176x · Cited by 1,243
Slotema, C. W., Blom, J. D., Hoek, H. W., & Sommer, I. E. C. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04872gre · Cited by 584
Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication.
Kirsch, I., & Sapirstein, G. (1998) · Prevention & Treatment · doi:10.1037/1522-3736.1.1.12a · Cited by 502
Khan, A., Warner, H. A., & Brown, W. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.311 · Cited by 477
Taylor, M. J., Freemantle, N., Geddes, J. R., & Bhagwagar, Z. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1217 · Cited by 406
“Trials were identified by (1) searching CENTRAL, The Cochrane Collaboration database of controlled trials (in The Cochrane Library, issue 1, 2005; using the search terms SSRI or fluoxetine or fluvoxamine or citalopram or escitalopram or sertraline or paroxetine and the key words placebo and depression); (2) the refere…”
MethodSchutter, D. J. L. G. (2009) · Psychological Medicine · doi:10.1017/s0033291708003462 · Cited by 371
Antidepressants versus placebo for depression in primary care
Arroll, B., Elley, C. R., Fishman, T., Goodyear-Smith, F. A., Kenealy, T., Blashki, G., Kerse, N., & MacGillivray, S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007954 · Cited by 352
Arroll, B. (2005) · The Annals of Family Medicine · doi:10.1370/afm.349 · Cited by 351
Meta-analysis of the placebo response in antidepressant trials.
Rief, W., Nestoriuc, Y., Weiss, S., Welzel, E., Barsky, A. J., & Hofmann, S. G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.029 · Cited by 346
Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not Glucose
Craft, S., Asthana, S., Newcomer, J. W., Wilkinson, C. W., Matos, I. T., Baker, L. D., Cherrier, M., Lofgreen, C., Latendresse, S., Petrova, A., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1135 · Cited by 312
A meta-analysis of treatments for perinatal depression
Sockol, L. E., Epperson, C. N., & Barber, J. P. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.03.009 · Cited by 287
Guaiana, G., Barbui, C., & Hotopf, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004186.pub2 · Cited by 271
Antidepressants plus benzodiazepines for major depression
Furukawa, T. A., Streiner, D., Young, L. T., & Kinoshita, Y. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001026 · Cited by 161
Self-citationKaymaz, N., van Os, J., Loonen, A. J. M., & Nolan, W. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0910 · Cited by 135
“The efficacy of antidepressants in treating acute episodes (4–6 and up to 12 weeks) has been well established in placebocontrolled studies, although the effect sizes for antidepressant treatment are only moderately larger than for placebo.(4,5) Moreover, antidepressants are effective in longterm treatment.”
Background. Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder.
Friedman, M. A., Detweiler-Bedell, J. B., Leventhal, H. E., Horne, R., Keitner, G. I., & Miller, I. W. (2004) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.bph052 · Cited by 123
An open-label, flexible-dose study of memantine in major depressive disorder
Ferguson, J. M., & Shingleton, R. N. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3180314ae7 · Cited by 113
Using epidemiological data to model efficiency in reducing the burden of depression
Andrews, G., Sanderson, K., Corry, J., & Lapsley, H. M. (2000) · The Journal of Mental Health Policy and Economics · doi:10.1002/mhp.96 · Cited by 110
“Refer to reference.(26) – 28,41 Costs of current care were based on a top-down approach, by using health system expenditure(7) on depression and dividing by the number of people with depression in treatment.”
MethodThe reluctance to seek treatment for neurotic disorders
Meltzer, H., Bebbington, P., Brugha, T., Farrell, M., Jenkins, R., & Lewis, G. (2003) · International Review of Psychiatry · doi:10.1080/0954026021000046038 · Cited by 109
“Treatments for neurotic disorder are reasonably effective (Joffe et al., 1996; Gould et al., 1997; Gloaguen et al., 1998; Jorgensen et al., 1998), and there is thus a public health imperative to improve this state of affairs.”
El Dib, R., Periyasamy, A. G., de Barros, J. L., França, C. G., Senefonte, F. L., Vesentini, G., Alves, M. G. O., Rodrigues, J. V. D. S., Gomaa, H., Gomes Júnior, J. R., et al. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.07.027 · Cited by 75
Jakobsen, J. C., Hansen, J. L., Simonsen, S., Simonsen, E., & Gluud, C. (2012) · Psychological Medicine · doi:10.1017/s0033291711002236 · Cited by 63
Moore, C. D., Schofield, C., van Rooyen, D. R. M., & Andersson, L. M. C. (2015) · SpringerPlus · doi:10.1186/s40064-015-1109-1 · Cited by 30
(2014) · Europe PMC (PubMed Central) · Cited by 25
Quality assessment of meta-analyses of RCTs of pharmacotherapy in major depressive disorder.
Hemels, M. E. H., Vicente, C., Sadri, H., Masson, M. J., & Einarson, T. R. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003197 · Cited by 23
The Adequacy of Reporting Randomized, Controlled Trials in the Evaluation of Antidepressants
Streiner, D. L., & Joffe, R. (1998) · The Canadian Journal of Psychiatry · doi:10.1177/070674379804301008 · Cited by 15
Self-citation
Metadata
- Authors
- Joffe, R., Sokolov, S., & Streiner, D.
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 1996-12
- Volume
- 41
- Issue
- 10
- Pages
- 613-616
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- OpenAlex
- W2132633462
- Cited by
- 116
- References
- 3
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.